Logo
Home
About Us
About UsTeam
Pipeline
PipelineATH434Multiple System AtrophyParkinsonian Disorders
The Science
ApproachPublications & Presentations
Investors
Investor OverviewPress ReleasesASX AnnouncementsEvents and PresentationsShare PriceCorporate GovernanceAnalyst Coverage
Synapse Sessions
Contact Us

ATH Shareholder Letter January 2026

Released

Latest announcements

Ask a question


Your question will be sent privately to Alterity Therapeutics. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Alterity Therapeutics a question about this announcement.